GL9.IR Glanbia plc (EURONEXT) 24 Feb 2026: earnings preview, guidance to watch
GL9.IR stock trades at EUR 16.68 intraday as Glanbia plc (GL9.IR) prepares to report results on 25 Feb 2026. Investors are focused on EPS and forward guidance after a year where EPS momentum slowed; the company reports EPS 0.40 and a trailing PE 40.98. Volume is active today at 1,191,043 shares versus an average of 471,976, reflecting higher attention ahead of the announcement. We examine what metrics can move the stock at EURONEXT and what the numbers imply for near-term trading.
Earnings preview: GL9.IR stock
Glanbia will report on 25 Feb 2026, and the market will watch reported EPS, segment margins and any update to FY guidance. The business mixes sports nutrition and dairy ingredients, so margin swings in ingredients or consumer channels could explain last year’s EPS decline. One key metric to watch is operating cash flow per share of EUR 1.32, which supports the dividend and capital allocation debate.
What to watch in the results: GL9.IR earnings
Expect commentary on margin recovery and cost management given FY 2024 saw net income decline -47.20% and EPS growth negative -51.16%. Management guidance on commodity costs and channel mix for brands like OPTIMUM NUTRITION and SlimFast will drive sentiment. Also watch free cash flow per share of EUR 1.15 and any comments on M&A or capital returns.
Valuation and sector context: GL9.IR analysis
GL9.IR stock trades at PE 40.98, well above the European Consumer Defensive average PE of 24.2, suggesting premium expectations. Price-to-sales is 1.13 and price-to-book is 2.43, while dividend yield sits near 2.47% with payout ratio 0.9458, which flags dividend sustainability if earnings remain weak. Relative to sector peers, Glanbia’s margin profile and higher valuation require proof of reaccelerating growth.
Technical and trading signals: GL9.IR trading
Intraday range is EUR 16.52–16.84 with current price EUR 16.68 and relative volume 1.36, so liquidity is healthy for trading around the print. Momentum indicators show RSI 52.07 and ADX 35.51 indicating a firm trend; Bollinger bands centre at EUR 16.60. Traders should watch post-earnings volatility; ATR is EUR 0.34 giving a short-term guide to expected move size.
Meyka AI grade and model forecast: GL9.IR forecast
Meyka AI rates GL9.IR with a score out of 100 at 70.47 (Grade B+, suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects quarterly EUR 17.92 (implied upside 7.44%) and yearly EUR 11.83 (implied downside -29.07%) versus current EUR 16.68; forecasts are model-based projections and not guarantees.
Risks and opportunities: GL9.IR outlook
Key risks include weak organic sales in consumer nutrition, higher input costs for cheese and dairy, and the high payout ratio that strains dividends if EPS stays low. Opportunities include brand momentum in sports nutrition, efficiency gains in the ingredients division, and any positive guidance lift from management. Market cap is EUR 3.97B, so any strategic update or bolt-on acquisition could move the stock materially.
Final Thoughts
Glanbia plc (GL9.IR) enters the earnings window with EUR 16.68 stock price, a high PE of 40.98, and active volume of 1,191,043 shares today on EURONEXT. The immediate market test is management’s guidance and cash flow clarity: free cash flow per share of EUR 1.15 and operating cash flow per share of EUR 1.32 will determine whether the dividend yield near 2.47% is sustainable. We view valuation as a key friction point — the stock trades at a premium to the Consumer Defensive peer group — so proof of margin recovery is required to sustain current levels. Meyka AI’s forecast model projects a near-term quarterly target of EUR 17.92 (implied upside 7.44%) but a longer 12‑month model projection of EUR 11.83 (implied downside -29.07%). For traders we recommend watching guidance, EPS, and operating cash flow; for longer term investors, consider a base case price target of EUR 17.50, conservative EUR 14.00, and bullish EUR 19.50, and re-evaluate after the results. Forecasts are model-based projections and not guarantees. For more live quotes and data visit the Glanbia page on Meyka AI Glanbia (GL9.IR) on Meyka. For historical data and the earnings calendar see Investing.com historical data and Investing.com earnings calendar.
FAQs
When does Glanbia (GL9.IR) report earnings and what matters most
Glanbia reports on 25 Feb 2026; investors should focus on EPS, margin commentary and operating cash flow. Management guidance on commodity costs and consumer channels will set the near-term trading range.
What is the current valuation and dividend yield for GL9.IR stock
GL9.IR stock trades at PE 40.98 with a dividend yield near 2.47% and payout ratio about 0.9458, which highlights sensitivity to EPS changes for dividend sustainability.
How does Meyka AI view GL9.IR and what are the forecasted levels
Meyka AI rates GL9.IR 70.47/100 (B+, BUY). The model projects quarterly EUR 17.92 (up 7.44%) and yearly EUR 11.83 (down -29.07%). Forecasts are projections, not guarantees.
What short-term technical levels should traders watch for GL9.IR stock
Watch intraday support near EUR 16.52 and resistance at EUR 16.84, ATR EUR 0.34 and Bollinger middle band EUR 16.60 for expected move guidance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.